Table 2.
Demographics and laboratory findings of survived and non-survived patients
| Survived (n = 189) mean ± SD/median (IQR) | Non-survived (n = 22) mean ± SD/median (IQR) | P | Z | |
|---|---|---|---|---|
| Age years | 58.1 ± 13.5 | 67.9 ± 12.5 | 0.005 | |
| Gender (F/M) | 69/120 | 7/15 | 0.665 | |
| Lesion size | 56.9 ± 30.6 | 75.2 ± 35.2 | 0.004 | -2.853 |
| WBC (10^3/uL) | 7.89 (7.63) | 11.96 (10.30) | 0.002 | -3.075 |
| Neutrophil (10^3/uL) | 5.09 (4.92) | 8.50 (7.71) | 0.002 | -3.033 |
| Lymphocyte(10^3/uL) | 2.13 (2.01) | 2.08 (2.10) | 0.457 | -0.744 |
| NLR | 2.60 (2.24) | 4.28 (3.75) | <0.001 | -3.733 |
| Platelet (10^3/uL) | 259.0 ± 73.1 | 306.1 ± 65.9 | 0.028 | -2.203 |
| PLR | 134.2 (124.0) | 150.2 (145.0) | 0.038 | -2.079 |
| Hemoglobin mg/dl | 13.0 ± 1.8 | 12.4 ± 1.6 | 0.001 | -3.371 |
| MPV | 7.24 (7.20) | 7.13 (7.86) | 0.430 | -0.790 |
| Creatinine mg/dl | 0.9 ± 0.3 | 1.2 ± 0.8 | 0.046 | -1.996 |
| CT density (HU) | ||||
| Unenhanced | 32.9 ± 1.4 | 29.7 ± 3.1 | 0.401 | |
| Corticomedullary | 110.8 ± 5.3 | 81.4 ± 10.1 | 0.048 | |
| Nephrographic | 86.5 ± 3.1 | 73 ± 5.3 | 0.118 | |
| Excretory | 64.2 ± 2.5 | 59 ± 4.4 | 0.522 | -0.640 |
| Metastasis | 44 | 12 | 0.002 | 9.88 chi-square |
| Pathologies Clearcell/Nonclear cell | 103/86 | 16/6 | 0.103 | |
| Chromophobe/ Papillary/Mix/Sarcomatoid | 29/25/29/2 | 1/0/3/2 | 0.692 | |
| Tumor Stage 1/2/3/4 | 105/27/13/44 | 7/1/2/12 | 0.005 | -2.788 |
IQR: interquartile range, WBC: White blood cell count, NLR: Neutrophil-lymphocyte ratio, PLR: Platelet-lymphocyte ratio, MPV: Mid-platelet volume, CT: Computed tomography, HU: Hounsfeld unit.